VENERONI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 769
EU - Europa 543
AS - Asia 372
OC - Oceania 5
AF - Africa 1
Totale 1.690
Nazione #
US - Stati Uniti d'America 766
CN - Cina 336
IE - Irlanda 176
UA - Ucraina 98
FI - Finlandia 78
DE - Germania 63
IT - Italia 58
GB - Regno Unito 25
SG - Singapore 25
BE - Belgio 15
SE - Svezia 14
FR - Francia 8
IN - India 5
AU - Australia 4
CA - Canada 2
CZ - Repubblica Ceca 2
JP - Giappone 2
NL - Olanda 2
TR - Turchia 2
CH - Svizzera 1
CR - Costa Rica 1
ES - Italia 1
ID - Indonesia 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 1.690
Città #
Dublin 176
Chandler 172
Jacksonville 113
Nanjing 79
Ashburn 60
Beijing 60
Ann Arbor 54
Boardman 43
New York 40
Nanchang 36
Helsinki 35
Hebei 31
Lawrence 26
Medford 26
Princeton 26
Changsha 24
Jiaxing 23
Shanghai 22
Pavia 18
Shenyang 18
Wilmington 17
Singapore 16
Brussels 15
Tianjin 14
Seattle 11
Hangzhou 10
Milan 10
Woodbridge 10
Norwalk 7
San Francisco 7
Verona 7
Dearborn 5
Des Moines 3
Los Angeles 3
Ningbo 3
Pune 3
Washington 3
Canberra 2
Fairfield 2
Kunming 2
Munich 2
Tokyo 2
Zhengzhou 2
Albinea 1
Atlanta 1
Auckland 1
Berlin 1
Biandronno 1
Brescia 1
Brno 1
Cheyenne 1
Esslingen am Neckar 1
Fuzhou 1
Haikou 1
Houston 1
Jinan 1
Kemerovo 1
La Canada Flintridge 1
Lanzhou 1
London 1
Madrid 1
Orange 1
Ottawa 1
Phoenix 1
Prague 1
Rabat 1
Redmond 1
Rovellasca 1
Sacramento 1
San José 1
Scuola 1
Silver Spring 1
Surabaya 1
Sydney 1
Toronto 1
Travaco Siccomario 1
Varese 1
Totale 1.272
Nome #
[Pt(O,O'-acac)(γ-acac)(DMS)] versus cisplatin: apoptotic effects in B50 neuroblastoma cells. 99
Different patterns of apoptosis in response to cisplatin in b50 neuroblastoma rat cells. 93
Multiple organelle photodamage in HeLa cells treated with the fluorogenic substrate, hypocrellin B acetate 86
Distribution of Parp-2 and tankyrases in apoptotic cells 85
Distribution of centromeric proteins and PARP-1 during mitosis and apoptosis 80
Relationship between centromeric proteins and PARP-1during mitosis and apoptosis 78
Changes of mitochondria and relocation of the Apoptosis Inducing Factor (AIF) during apoptosis 78
Changes of mitochondria and relocation of the Apoptosis Inducing Factor (AIF) during apoptosis 76
Long-term effects after treatment with platinum compounds, cisplatin and [Pt(O,O'-acac)(γ-acac)(DMS)]: Autophagy activation in rat B50 neuroblastoma cells. 76
Multiple organelle photodamage in HeLa cells treated with the fluorogenic substrate, hypocrellin B acetate 75
Distribution of centromeric proteins and PARP-1 during mitosis and apoptosis 69
Effects of c-myc amplification on the cellular response of human cells to Paclitaxel. 66
Effects of cisplatin on neuronal cell B50: involvement of mitochondria in apoptosis induction. 63
Long-term exposure of undifferentiated neuroblastoma rat cells (B50) with platinum compounds induces autophagy. 63
Effects of Cisplatin in Neuroblastoma Rat Cells:Damage to Cellular Organelles 62
Ultrastructural immunolocalization of the senescence-related protein terminin in human fibroblasts. 59
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 59
Intracellular distribution of Tankyrases as detected by multicolor immunofluorescence techniques 58
Mitochondrial fusion a mechanism of cisplatin-induced resistance in neuroblastoma cells? 57
Squaring the Circle: A New Study of Inward and Outward-Rectifying Potassium Currents in U251 GBM Cells 56
Cell proliferation, apoptosis and mitochondrial damage in rat B50 neuronal cells after cisplatin treatment. 53
In vitro senescence of myotubes derived from myoblasts of patients affected by myotonic dystrophy type 2 (DM2): ultrastructural evidence 52
Analysis of ERK3 intracellular localization: dynamic distribution during mitosis and apoptosis. 52
The Apoptosis-Inducing Factor (AIF) Moves from Mitochondria to the Nucleus and Back to the Cytoplasm, during Apoptosis 43
Ultrastructural characterization of the MBNL1-containing foci occurring in myoblast and myotube nuclei from patients affected by myotonic dystrophy type 2 (DM2). 42
In vitro oxidative burst assay to evaluate the efficacy of immune-G-matrix™an innovative yeast-beta-glucans, zinc and copper-based formulation 42
Totale 1.722
Categoria #
all - tutte 6.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.345


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020136 0 0 0 0 0 26 4 24 4 48 28 2
2020/2021189 22 19 3 19 7 22 2 31 14 22 23 5
2021/2022124 1 3 2 1 2 5 2 6 4 2 21 75
2022/2023505 52 52 5 43 54 46 0 24 205 4 10 10
2023/2024225 35 26 6 10 14 75 17 25 2 4 5 6
2024/202580 8 33 24 9 6 0 0 0 0 0 0 0
Totale 1.722